This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Buchanan J, Fleischmann R, Genovese MC, Kay J, Hsia EC, Doyle MK, Rahman MU, Han C, Parasuraman S.Golimumab, a human anti-TNF-alpha monoclonal antibody, significantly improves self-reported productivity in patients with rheumatoid arthritis: results from three phase 3 studies. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: 557 abstr. PMS65, 8 Nov 2008
Rights and permissions
About this article
Cite this article
Golimumab gets the green light for QOL in RA. Pharmacoecon. Outcomes News 568, 9 (2008). https://doi.org/10.2165/00151234-200805680-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805680-00023